About Altos Labs
Altos Labs is an American biotechnology research company founded in 2022, specializing in cellular rejuvenation programming aimed at restoring cell health and resilience to reverse diseases and transform medicine. The company operates in San Francisco, San Diego, and Cambridge, UK, and has established significant collaborations in Japan. Its Board of Directors and advisory team include Nobel Laureates and prominent scientific leaders.
Altos Labs Industries Press Mentions
Stay in the know about the latest news on Altos Labs Industries
Investors in Altos Labs Industries
Discover investors in Altos Labs Industries stock and explore their portfolio companies
Altos Labs Industries Management
Leadership team at Altos Labs Industries
Management Team
Hans Bishop
Co-Founder & President
Ann Lee-Karlon Ph.D
Chief Operating Officer
Hal Barron MD
Chief Executive Officer
Richard Klausner MD
Co-Founder & Chief Scientist
Register To Buy and Sell Shares
For more details on private stock price information, financing and valuation for Altos Labs, register or login.
- Altos Labs's current valuation
- Altos Labs's stock price
- Explore available deals for Altos Labs and other companies
- Access deal offering documents
- Pre-Ipomarket's exclusive data and insights, including:
- Cap tables showing funding history by Share Class and Liquidity Preferences
- Key Company Highlights
- Detailed Business Model
- Identified Risk Factors
By registering, you agree to StockMe's Terms of Use. Already registered? Log in
Frequently Asked Questions
How to invest in Altos Labs shares?
Accredited investors can purchase pre-IPO stock in companies like Altos Labs through platforms like pre-ipomarket. These shares are typically offered by early employees who are seeking liquidity for personal life events, such as buying a home or funding education. Investors can access these opportunities through funds similar to those used by hedge funds for large investors. While private company investments come with risks, they offer the potential for portfolio diversification, access to growth, and high returns. Learn more about our guided investment process.
How to sell Altos Labs shares?
Shareholders have the option to sell their Altos Labs stock through pre-ipomarket’s private company marketplace. The platform connects sellers with a large network of accredited investors who are interested in purchasing shares of private companies. Learn more about the streamlined and guided process for shareholders here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on pre-ipomarket. The first is if the company undergoes an exit event, such as an IPO, merger, or acquisition. In such cases, your shares and/or cash will be distributed directly to you. The second option, if eligible, is through an Express Deal. This allows you to sell your allocation of private shares in a specific company to another investor via the pre-ipomarket platform.
Why choose Pre-Ipomarket?
pre-ipomarket has simplified the process of buying and selling shares in private companies. The platform connects investors with shareholders, offering liquidity to early shareholders and providing accredited investors with access to private market opportunities. With low investment minimums and over 42K private placements completed across 450+ companies, pre-ipomarket is a leader in making "Private Markets for the Public."
